Ancora launches European clinical test of ventricle-binding therapy for heart failure

Ancora Heart kicked off a European clinical study for its device designed to directly repair an enlarged left ventricle from the inside, as a treatment for patients suffering from heart failure.

Sourced through Scoop.it from: www.fiercebiotech.com